Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.5310
-0.0285 (-5.09%)
Jul 21, 2025, 3:59 PM EDT
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $599.09 million as of July 21, 2025. Its market cap has increased by 199.90% in one year.
Market Cap
599.09M
Enterprise Value
598.69M
Revenue
84.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.53
Market Cap Chart
Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 599.09M, an increase of 6,156.69%. That is a compound annual growth rate of 16.55%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.61B |
| Veradigm | 832.17M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 434.24M |
| CytoDyn | 394.89M |
| Northwest Biotherapeutics | 386.15M |
| American Oncology Network | 321.34M |